Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population

NCT03742271 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Visual Acuity

Interventions

DEVICE: senofilcon A

Sponsor

Johnson & Johnson Vision Care, Inc.